The document is a technical presentation by FUNDS LLC PRIVIUM, detailing the intellectual property portfolio, physiochemical properties, insulin specifications, HPLC results, related substances, peptide mapping, and electrophoretic patterns of their generic insulin product. The presentation highlights the equivalence of their generic insulin to USP Grade Insulin in terms of physiochemical properties and specifications, and demonstrates the purity and reduced contaminants of their product compared to the USP standard.
documents/EFTA00596375.pdf
{}